From the Co-Chairs

December 20, 2022

From the Co-Chairs, December 2022

Reflections on NCI-MATCH and its successor trials; research results in leukemia and breast cancer; and grant renewal preparations
October 13, 2022

From the Co-Chairs, October 2022

Research results in breast and kidney cancer; recognition of key colleagues; and a sneak peek of the Fall 2022 Group Meeting
August 16, 2022

From the Co-Chairs, August 2022

President Biden to appoint Dr. Monica Bertagnolli as NCI Director; NCI-MATCH trial data leads to FDA drug approval
June 21, 2022

From the Co-Chairs, June 2022

Reflections on the spring conference season, including highlights from the Spring Group Meeting and ASCO's Annual Meeting
April 15, 2022

From the Co-Chairs, April 2022

Congress creates a new health care research agency; NCI-MATCH continues to offer treatment options; ECOG-ACRIN plans for first in-person Group Meeting since 2019
February 24, 2022

From the Co-Chairs, February 2022

Reflections on the 50th Anniversary of the National Cancer Act of 1971
January 26, 2022

From the Co-Chairs, January 2022

Hopes for a return to normalcy in 2022—plus, recent qualitative research identifies surprising barriers to the long-term control of breast cancer
December 22, 2021

From the Co-Chairs, December 2021

The co-chairs reflect on key 2021 accomplishments, and share their thanks and best wishes for a happy New Year
November 16, 2021

From the Co-Chairs, November 2021

Practice-changing trial results in melanoma; Group and committee leadership updates; remembering a dear colleague and friend
October 19, 2021

From the Co-Chairs, October 2021

A focus on the Fall 2021 ECOG-ACRIN Group Meeting; remembering two major leaders in oncology; studying smoking cessation in patients with cancer
September 30, 2021

From the Co-Chairs, September 2021

A focus on leukemia trials; an update regarding advanced practice providers; two important topics related to patient communication
August 23, 2021

From the Co-Chairs, August 2021

Fall 2021 Group Meeting to be virtual; a new prevention trial; the case for COVID-19 vaccination